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Abstract
Purpose The opposing carcinogenic and antiestrogenic
properties of tobacco smoke may explain why epidemiol-
ogic studies have not consistently reported positive associ-
ations for active smoking and breast cancer risk. A negative
relation between mammographic density, a strong breast
cancer risk factor, and active smoking would lend support
for an antiestrogenic mechanism.
Methods We used multivariable linear regression to
assess the associations of active smoking and secondhand
smoke (SHS) exposure with mammographic density in 799
pre- and early perimenopausal women in the Study of
Women’s Health Across the Nation (SWAN).
Results We observed that current active smoking was
associated with 7.2% lower mammographic density, com-
pared to never active smoking and no SHS exposure
(p = 0.02). Starting to smoke before 18 years of age and
having smoked C20 cigarettes/day were also associated
with statistically signiﬁcantly lower percent densities.
Among nulliparous women having smoked C20 cigarettes/
day was associated with 23.8% lower density, compared to
having smoked B9 cigarettes/day (p\0.001).
Conclusions Our ﬁndings support the hypothesis that
tobacco smoke exerts an antiestrogenic effect on breast
tissue, but counters the known increased risk of breast
cancer with smoking prior to ﬁrst full-term birth. Thus, our
data suggest that the antiestrogenic but not the carcinogenic
effects of smoking may be reﬂected by breast density.
Keywords Breast cancer risk factor  Breast density 
Cigarette smoking  Mammographic density 
Secondhand smoke
Introduction
In vivo data provide evidence that several tobacco smoke
constituents act as breast carcinogens [1, 2]. Although
cigarette smoking is a likely risk factor for breast cancer
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vational data are by no means consistent [6, 7]. However,
smoking exposure during the pre-partum period, or time
prior to a woman’s ﬁrst full-term birth (FFTB), when breast
tissue is less differentiated [8], appears to be most relevant
for breast cancer risk [9–13]. Duration and early age at
secondhand smoke (SHS) exposure among women who
have never actively smoked have also been associated with
a modest increased risk of breast cancer [14, 15].
The complex mixture of chemicals in tobacco smoke
condensate include not only compounds with carcinogenic
properties [1] but also compounds with antiestrogenic
properties [16] that may act by disturbing gonadotropin
release [17–19] or inhibiting aromatase activity [20].
Observational studies provide more consistent evidence for
an indirect antiestrogenic effect of tobacco smoke. For
example, smoking has been associated with health issues
related to menstrual and ovarian disruption, such as infer-
tility [21], earlier age at menopause [22], and decreased
bone density [23]. In contrast, few data support direct
effects, such as lower serum estradiol levels among pre-
menopausal current smokers versus nonsmokers [24–26].
Percent mammographic density, or the percentage of
total breast tissue area that is radiologically dense, has been
associated with an average four- to six-fold increase in
breast cancer risk, when comparing C60% to little or no
density [27]. While current smoking has been consistently
reported to be inversely associated with percent mammo-
graphic density among premenopausal women [28–31],
less consistent ﬁndings have been reported among post-
menopausal women, with one study reporting an inverse
association [32], and others reporting no association [29,
31, 33]. The inconsistently reported positive associations
between smoking and breast cancer risk and inverse asso-
ciations between smoking and breast density suggest dual,
opposing effects of tobacco smoke on breast tissue.
Few data are available that go beyond evaluating
dichotomized smoking status and mammographic density.
In addition, most prior studies of smoking and mammo-
graphic density have not evaluated SHS exposure, with one
exception [28]. The aim of this study was to use detailed
active smoking and SHS exposure data to evaluate whether
smoking status, and other smoking characteristics were
associated with percent mammographic density in a mul-
tiethnic cohort of pre- and early perimenopausal women.
Materials and methods
Study population
This study was conducted among a subset of participants
enrolled in the Study of Women’s Health Across the
Nation (SWAN) who provided mammograms. SWAN is a
community-based, longitudinal study designed to evaluate
women though the menopausal transition [34]. Three
SWAN sites, University of California Davis-Kaiser (Oak-
land), University of California Los Angeles (Los Angeles)
and University of Pittsburgh (Pittsburgh), participated in
the mammographic density ancillary study. To be eligible
to enter the SWAN cohort, women had to be between 42
and 52 years of age, to have reported having had a men-
strual period and no use of exogenous hormones within the
3 months prior to recruitment, and to have identiﬁed their
primary race as African-American (Pittsburgh), Japanese
(Los Angeles), Chinese (Oakland), or Caucasian (all sites).
To identify women from the general population, two sites
(Los Angeles, Pittsburgh,) used random digit dialing-
sampling, and one site selected randomly from a healthcare
organization membership listing (Oakland). Of the 1,248
women in follow-up at these three SWAN sites at the time
of enrollment into the ancillary study (i.e. at the ﬁfth or
sixth annual follow-up visit), 85% agreed to participate. Of
those who participated, 1,005 (95%) had at least one eli-
gible mammogram for density assessment.
Mammographic density declines through the meno-
pausal transition [35]. For this reason, women were
included in these analyses only if they were pre- or early
perimenopausal at the time of their index mammogram to
evaluate tobacco smoke exposure at a time closest to that
of peak breast density. Based on SWAN criteria [36],
premenopausal status was deﬁned as menses in the past
3 months, with no change over the past year in predict-
ability of menstrual periods [37, 38]. Early perimenopausal
status was deﬁned as menses in the past 3 months with
some change in the predictability of menstrual periods over
the past year.
A total of 799 pre- or early perimenopausal women had
an eligible mammogram and complete smoking data
available for these analyses (391 non-Hispanic white, 60
African-American, 169 Japanese, and 179 Chinese). Both
the core SWAN protocol and the protocol for the mam-
mographic density ancillary study were approved by
Institutional Review Boards at all institutions participating
in this ancillary study.
Exposure assessment
Active smoking history and secondhand smoke exposure
Active smoke exposure was assessed using a self-admin-
istered questionnaire at baseline and each subsequent
follow-up visit using seven questions adapted from the
American Thoracic Society [39]. SHS exposure within the
past 7 days was assessed among never- or former-active
smokers using a self-administered questionnaire at baseline
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123and at follow-up visit 03 using seven questions adapted
from a validated questionnaire [40]. Participants were
asked about number of people, days and hours of tobacco
smoke exposure inside the home and while at work, and
hours of exposure while at places other than home or work
(including meetings, restaurants, bars, parties, etc.). Par-
ticipant responses at baseline (n = 676) or the follow-up
visit (n = 267) closest to the woman’s index mammogram
were used to determine smoking status (never/no SHS,
never/with SHS, former, current), age at initiation, smok-
ing intensity (cigarettes/day), years smoked, pack-years,
years since quitting (among former-active smokers), and
person-hours of SHS exposure (among never and former
active smokers). Ever-active smokers were deﬁned as
having smoked a total of at least 20 packs of cigarettes over
their lifetime, or at least one cigarette per day for at least
1 year. Former-active smokers were deﬁned as ever-active
smokers who reported no longer smoking at the time of
interview. Only seven women changed from current to
former active smokers, and one woman changed from
former to current active smoker status during follow-up,
among the women with smoking data from a follow-up
visit. Presence of SHS exposure was deﬁned as at least one
total person-hour of SHS exposure during the past 7 days.
Person-hours of SHS were calculated as follows: for
example, if a participant reported being exposed to tobacco
smoke by one person for 2 h every day over the past 7 days
in their home, no exposure while at work, and 3 h for 1 day
over the past 7 days while at a restaurant, then the total
person-hours of SHS exposure would be 17. Changes from
no SHS exposure at baseline to C1 person-hours during
follow-up were reported by 16 women, and 13 women
changed from C1 person-hours to no SHS exposure.
Other factors
At baseline (1996–1997), in-person, interviewer-adminis-
tered questionnaires were used to obtain information on
date of birth, race/ethnicity, highest level of education,
family history of breast cancer, and menstrual and repro-
ductive factors. At baseline and at each annual follow-up
visit starting in 1997, information was collected on annual
household income, hormone use, gynecologic events
(including menopausal status), weight and height, and
alcohol use. For annually collected data, we used the
responses collected at the visit closest to a woman’s index
mammogram.
Mammographic density
Eligible mammograms were those taken as part of routine
medical care during the period from 2 years prior to the
baseline examination through 2 years after annual follow-
up visit 06. If multiple mammograms were available for a
given participant, then the mammogram closest to, either
preceding or following, the baseline visit was selected.
Quantitative assessment was made by Martine Salane,
an established expert in the techniques of measuring
mammographic density [41]. Ms. Salane’s measurements
have been highly correlated with computer-assisted density
measurements (r = 0.90) [42]. The total area of the breast
and the areas of dense breast were measured with a com-
pensating polar planimeter (LASICO, Los Angeles, CA) on
the craniocaudal view of the right breast. Mammograms
from the left breast were used for density assessments
when ﬁlms from the right breast were unavailable
(n = 81). Percent density was calculated by dividing the
area of dense breast by the total area of the breast and
multiplying by 100.
Statistical methods
The primary goal of these analyses was to assess whether
tobacco smoke exposure was related to percent mammo-
graphic density. Transformation was not needed to nor-
malize the distribution of percent mammographic density.
Statistical computing was conducted using SAS version 9.1
(SAS Institute Inc., Cary, NC, USA).
Independent variables
The main independent variables of interest were smoking
status (never-active/without SHS, never-active/with SHS,
former-active, current-active), person-hours of SHS expo-
sure (among never- and former-active smokers, separately),
years since stopped smoking (among former-active smok-
ers), and among ever-active smokers: age at starting to
smoke (C18, \18 years), average number of cigarettes
smoked per day (B9, 10–19, C20), years smoked (B9, 10–
19, 20–29, C30), and pack-years of smoking (\, C med-
ian = 7.5). We also assessed whether age at starting to
smoke with respect to age at menarche and age at FFTB
was important in analyses stratiﬁed by parity.
Covariates
The following variables were assessed as potential con-
founders: age, body mass index (BMI), race/ethnicity,
study site, education level, household income, age at
menarche, parity, menopausal status, oral contraceptive
use, other hormone use, alcohol consumption, and family
history of breast cancer [43–46]. In addition, a combined
variable race/ethnicity-study site was created, because each
study site recruited women from a single race/ethnic group
in addition to non-Hispanic whites. For example, Chinese
Cancer Causes Control (2010) 21:301–311 303
123women were recruited in Oakland, Japanese women in Los
Angeles, and African-American women in Pittsburgh.
Bivariate analyses were conducted to study mean
mammographic density levels in relation to each covariate
using ANOVA or simple linear regression, depending on
variable type. If a covariate was associated with mammo-
graphic density based on the bivariate analyses, it was
individually added into a base model with smoking status
(never-active smoker/no SHS, never-active smoker/with
SHS, former active, current active). The following covar-
iates were included in the ﬁnal adjusted model, because
they resulted in a 10% or greater change in the beta esti-
mates for smoking status: age (40–44, 45–49, 50–
55 years), BMI (continuous and\25.0, 25–29.9, C30.0 kg/
m
2), race/ethnicity-study site (non-Hispanic white-Oak-
land, Chinese-Oakland, non-Hispanic white-Los Angeles,
Japanese-Los Angeles, non-Hispanic white-Pittsburgh,
African American-Pittsburgh). Additionally, the following
covariates were added because of their associations with
smoking status and mammographic density in these data
[47]: age at menarche (\12, 12, 13, C14 years), parity (0,
1–2, C3 full-term births), alcohol consumption (abstainer,
C1 drinks/week), and oral contraceptive use (never, ever).
Finally, we examined whether the association between
percent mammographic density and smoking status varied
by the following factors: age, BMI, race/ethnicity-study
site, menopausal status, parity and alcohol consumption by
performing both stratiﬁed analyses, and ﬁtting of interac-
tion terms in adjusted models.
Results
Our cohort of 799 women had a mean age of 47 years,
almost half were non-Hispanic white, and a majority were
classiﬁed as never-active smokers, with 37% of never-
active smokers reporting at least one person-hour of SHS
exposure in the last 7 days (Table 1). Percent mammo-
graphic density was nearly normally distributed (skew-
ness =- 0.1; kurtosis = 0.9), with a mean of 44.4
(standard deviation = 20.4) and a median of 45.9 (inter-
quartile range = 29.3). We have previously reported that
percent mammographic density was inversely associated
with older age, higher BMI, previous oral contraceptive
use, and greater number of births [48].
Mean percent mammographic density decreased across
smoking status categories associated with increased tobacco
smoke exposure, with the lowest percent density among
current active smokers (Table 1). Ever-active smokers,
compared to never-active smokers/without SHS were more
likelytobenon-HispanicwhiteandlesslikelytobeChinese,
had lower education, higher BMI, were more likely to
consume alcohol, ever use oral contraceptives, or have a
family history of breast cancer, and less likely to have had a
full-term birth (Table 1). Differences by SHS exposure
among never-active smokers were similar, for example,
never-activesmokersweremorelikelytobeexposedtoSHS
if they were non-Hispanic white, had higher BMI, and
consumed alcohol.
Results of the unadjusted linear regression models indi-
cated that, compared to never-active smokers without SHS,
the following groups had increasing inverse associations
with percent density: never active with SHS, former active,
and current active, respectively (Table 2). After adjustment
for potential confounders, all beta estimates for smoking
status categories were attenuated but remained statistically
signiﬁcant (Table 2). No difference was observed in the
magnitude of association for former-active (adjusted
beta =- 2.12) and current-active (adjusted beta =- 6.80),
smokers when never-active smokers (regardless of SHS
exposure) were used as the referent group (p\0.01).
Amount of person-hours of SHS exposure among never-
active smokers was inversely associated with percent
density, but the beta for [3 person-hours versus no SHS
was attenuated to the null after adjustment for potential
confounders (Table 2). The associations with smoking
status were not meaningfully different across strata of age,
BMI, race/ethnicity, menopausal status, or alcohol con-
sumption (data not shown). The associations with smoking
status were also similar when we restricted analyses to non-
Hispanic whites (n = 391) (adjusted beta for current-active
smoker versus never smoker/no SHS =- 7.40, p for
smoking status = 0.08).
Among former-active smokers, we did not observe a
trend for years since stopped smoking and percent density
(Table 2). Among ever-active smokers, characteristics
inversely associated with percent density included younger
age at starting to smoke, more cigarettes smoked per day,
and more pack-years (Table 2). Only the inverse associa-
tion with pack-years lost statistical signiﬁcance after
adjusting for potential confounders (Table 2).
Next, we evaluated whether associations between dif-
ferent measures of active smoking characteristics and
percent density differed for parous and nulliparous women
(Table 3). Starting to smoke within 5 years of menarche
was not associated with percent density among either
nulliparous or parous ever-active smokers. A non-statisti-
cally signiﬁcant inverse association was observed for
starting to smoke before a FFTB. Earlier age at starting to
smoke was inversely associated with percent density
among both groups, with a stronger association among
parous ever-active smokers (p for interaction by par-
ity = 0.6). The strongest inverse association was observed
for smoking intensity among nulliparous ever smokers,
with a trend of lower density with more cigarettes per day
(p for interaction by parity\0.001).
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123Table 1 Distribution of study population characteristics
a by smoking status
Never smoker/no SHS
b Never smoker/with SHS
b Former smoker Current smoker p-value comparing never/no
SHS to ever smokers
n (%) 344 (43) 203 (25) 179 (22) 73 (9)
Mean percent mammographic
density (95% CI)
c
48.5 (46.3, 50.6) 43.1 (40.3, 45.8) 40.7 (37.7, 43.6) 38.4 (33.7, 43.0) \0.001
n % n % n % n %
Characteristics
Age (years) 0.63
40–44 90 26 53 26 44 25 23 32
45–49 198 58 115 57 96 54 41 56
50–55 56 16 35 17 39 22 9 12
Race/ethnicity \0.001
Non-Hispanic white 132 38 109 54 114 64 36 49
African-American 11 3 18 9 16 9 15 21
Chinese 131 38 37 18 9 5 2 3
Japanese 70 20 39 19 40 22 20 27
Highest education level 0.04
High school graduate or less 56 16 35 17 19 11 19 26
Some college 87 25 61 30 57 32 31 43
College graduate or more 201 58 107 53 103 58 23 32
Body mass index, kg/m
2 \0.001
\25.0 228 67 100 50 84 48 37 52
25.0–29.9 71 21 51 25 48 27 18 25
C30 40 12 51 25 43 25 16 23
Alcohol, drinks/week \0.001
Abstainer 277 81 133 67 110 62 37 52
C16 6 1 9 6 7 3 4 6 8 3 8 3 4 4 8
Age at menarche, years 0.06
\12 61 18 47 23 42 24 15 21
12 89 26 58 29 56 31 25 35
13 112 33 60 30 47 26 15 21
[13 79 23 38 19 34 19 17 24
Parity
Nulliparous 51 15 40 20 42 23 14 19
Parous 293 85 163 80 137 77 58 81 0.02
1–2 full-term births 213 62 113 56 100 56 39 54 0.06
C3 full-term births 80 23 50 25 37 21 19 26
Menopausal status 0.45
Early perimenopausal 179 52 118 58 97 54 42 58
Premenopausal 165 48 85 42 82 46 31 42
Ever used oral contraceptives \0.001
No 111 32 53 26 29 16 16 22
Yes 232 67 148 73 148 83 57 78
Breast cancer family history 0.07
None 251 74 143 71 120 68 47 64
C1 ﬁrst degree relative 57 17 35 17 42 24 19 26
C1 second degree relative 32 9 24 12 15 8 7 10
a Data was from baseline (race/ethnicity, education, age at menarche, parity, oral contraceptive use, family history, secondhand smoke exposure) or from
the closest annual follow-up visit closest to the woman’s index mammogram (age, body mass index, alcohol, menopausal status, active smoking)
b Secondhand smoke (SHS) exposure is based on self-reported person-hours (#people x #days 9 hours) of exposure in past 7 days at home, work and
other sources
c Conﬁdence interval, CI
Cancer Causes Control (2010) 21:301–311 305
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Using cross-sectional data from a cohort of pre- and early
perimenopausal women, we observed that current active
smoking was associated with a statistically signiﬁcant, 7.2
percent lower mammographic density, compared to never
having actively smoked and without SHS exposure. In
addition, starting to smoke before 18 years of age (vs.
C18 years), and having smoked 20 or more cigarettes per
day (vs. B9) were also associated with a statistically
Table 2 Smoking in relation to percent mammographic density
n (%) Univariate models p-value Adjusted models p-value Adjusted mean
percent density
c
95% CI
d
Beta estimate (SE)
a Beta estimate (SE)
b
Smoking status \0.001 0.02
Never smoker/no SHS
e 344 (43) 0.0 0.0 45.6 43.8, 47.5
Never smoker/with SHS 203 (25) -5.38 (1.78) -0.94 (1.60) 44.9 42.6, 47.3
Former smoker 179 (22) -7.80 (1.85) -2.53 (1.71) 43.3 40.8, 45.8
Current smoker 73 (9) -10.08 (2.59) -7.24 (2.41) 38.8 34.7, 42.9
Never smokers
SHS exposure, person-hours per week 0.02 1.0
0 344 (63) 0.0 0.0 45.7 43.8, 47.6
1 71 (13) -5.17 (2.60) -0.35 (2.29) 44.8 40.9, 48.7
2–3 63 (12) -7.05 (2.74) -1.44 (2.47) 43.8 39.6, 48.0
[3 69 (13) -4.08 (2.63) -0.43 (2.39) 45.6 41.6, 49.6
Former smokers
Years since stopped smoking 0.15 0.11
C21 54 (32) 0.0 0.0 42.6 38.1, 47.1
16–20 33 (19) 3.19 (4.46) 3.37 (3.92) 45.3 39.4, 51.1
11–15 34 (20) -7.79 (4.42) -5.65 (3.94) 36.4 30.6, 42.3
B10 49 (29) -2.24 (3.98) -4.55 (3.44) 37.0 32.3, 41.7
Ever smokers
Age starting to smoke, years 0.01 0.04
C18 148 (60) 0.0 0.0 41.9 39.2, 44.6
\18 100 (40) -6.51 (2.63) -4.87 (2.38) 36.4 33.0, 39.8
Average cigarettes smoked per day 0.04 0.02
B9 77 (31) 0.0 0.0 43.6 39.8, 47.4
10–19 73 (29) -5.79 (3.34) -5.68 (2.89) 39.2 35.3, 43.2
C20 74 (29) -8.17 (3.33) -8.09 (2.91) 36.3 32.4, 40.2
Years smoked 0.6 0.3
B9 60 (24) 0.0 0.0 43.5 39.2, 47.8
10–19 75 (30) -4.16 (3.56) -2.69 (3.07) 39.7 35.9, 43.5
20–29 79 (31) -3.73 (3.52) -5.69 (3.04) 37.3 33.6, 41.1
C30 33 (13) -5.01 (4.46) -3.75 (4.09) 37.8 31.5, 44.2
Pack-years smoked 0.03 0.15
\Median
f 108 (50) 0.0 0.0 41.9 38.5, 45.3
CMedian 110 (50) -6.15 (2.78) -3.61 (2.48) 37.3 34.4, 40.3
a Parameter estimates for each factor modeled individually, in separate models. SE standard error
b Parameter estimates for each factor modeled individually, in separate models, and adjusted for age, body mass index, race/ethnicity-study site,
age at menarche, parity, alcohol consumption, and oral contraceptive use. SE standard error
c Mean values are adjusted for age, body mass index, race/ethnicity-study site, age at menarche, parity, alcohol consumption, and oral
contraceptive use
d Conﬁdence interval, CI
e Secondhand smoke (SHS) exposure is based on self-reported person-hours (#people 9 #days 9 hours) of exposure in past 7 days at home,
work and other sources
f Median = 7.5 pack-years
306 Cancer Causes Control (2010) 21:301–311
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123signiﬁcant lower percent density among ever-active
smokers. Starting to smoke during puberty or pre-partum,
and duration of SHS exposure among never-active smokers
were not positively associated with percent density in our
data.
Our ﬁnding of an inverse association between current-
active smoking and percent mammographic density sup-
ports most [28–31] but not all [33] prior study results. The
latter study ﬁnding may have been subject to measurement
error [49] because smoking status was crudely deﬁned as
yes/no current smoker based on medical record data [33].
Our ﬁndings of inverse associations between mammo-
graphic density and earlier age at starting to smoke and for
more cigarettes smoked per day, and no association with
smoking duration were similar to ﬁndings from previously
published results among pre- and postmenopausal women
[28, 29].
We observed an interaction by parity for the association
between smoking intensity and percent density, with a 23.8
percent lower density among nulliparous, ever-active
smokers for 20 or more cigarettes per day (vs. B9), and no
association among parous, ever-active smokers. Breast
tissue has a greater number of undifferentiated structures
prior to a woman’s ﬁrst pregnancy [8] and is therefore
more susceptible to the effects of tobacco during this
period [50]. Our ﬁndings suggest that a long duration
of exposure, at high smoking intensity, to undifferenti-
ated breast tissue, is necessary to observe the strongest
antiestrogenic effects of smoking on breast density among
premenopausal women. These ﬁndings, however, should
be interpreted cautiously because the association among
nulliparous women was based on only 18 women.
Cigarette smoke may exert antiestrogenic effects by
inﬂuencing estrogen metabolism. Cigarette smoke constit-
uents, such as 3-methylcholanthrene and benzo(a)pyrene,
are potent inducers of cytochrome p450 (CYP) 1A1 [51–
53], the primary enzyme responsible for 2-hydroxylation
[54]. Estradiol 2-hydroxylation yields metabolites, such as
[2-hydroxyestrone (2-OHE)], that have antiestrogenic
properties [55]. Our group has previously reported a sta-
tistically signiﬁcant trend (p\0.0001) of increasing uri-
nary 2-OHE level with increasing amount of smoking
among pre- and early perimenopausal women in SWAN
[56]. Although it remains a possibility that smoking redu-
ces circulating estrogens by increasing excretion of estro-
gen metabolites, the effect of smoking is likely to be small.
The consideration of estrogen-alternative mechanisms
that explain the inverse association between smoking and
breast density is also relevant, given that the evidence for
endogenous estrogen levels and mammographic density
among premenopausal women is equivocal [57–59]. For
example, an estrogen-alternative mechanism for smoking
and density may involve the breast mitogen, insulin-like
growth factor-1 (IGF-1). IGF-1 levels are positively asso-
ciated with mammographic density [60], and lower levels
have been reported among current smokers [61–63].
Although experimental data indicate that cigarette
smoke suppresses adipogenesis [64], or the development of
fat cells from pre-adipocytes, we observed that active
smokers were more likely to have a BMI over 30 kg/m
2
compared to never-active smokers. We adjusted for BMI in
our ﬁnal models, because body size has a strong, inverse
association with lower percent mammographic density
[65]. However, there is still a small possibility that the
observed inverse association between current smoking and
mammographic density in our data was due in part to
residual confounding by body size.
The strengths of our study included detailed active
smoking information that provided the ability to examine
multiple aspects of smoking exposure, and timing with
menstrual and reproductive events. In addition, we col-
lected SHS information based on exposure in the home,
work, and other locations. A limitation, however, was that
the SHS exposure data were ultimately based on self-report
and only assessed at baseline and follow-up visit 03.
Although we used questions that have previously been
validated with nicotine measures [40], and we estimated a
relatively small change in SHS smoking status during
follow-up in the cohort, we cannot exclude the possibility
that our ﬁnding for no association with duration of SHS
exposure was due, in part, to non-differential misclassiﬁ-
cation. Our study power to assess differences between
current and former active smokers for smoking character-
istics was limited due to our relatively small percentage
(9%) of current-active smokers. However, our ﬁndings for
ever-active smokers were consistent with a previous study
of similar study size, with 34% current smokers, for
smoking characteristics among current smokers and per-
cent density [28]. Although the multiethnic nature of our
cohort improved the generalizability of our ﬁndings to the
US population, our small numbers of African-Americans
and Japanese, for example, may have limited our ability to
fully adjust for confounding by race/ethnicity.
Conclusions
In our cohort of pre- and perimenopausal women, we
observed statistically signiﬁcant inverse associations with
percent mammographic density for current-active smoking,
starting to smoke before age 18 and smoking 20 or more
cigarettes per day, and no association with duration of SHS
exposure among never-active smokers. In addition, we
observed a statistically signiﬁcant interaction with parity
where mammographic density was lower among nullipa-
rous but not parous smokers. This observation, although
308 Cancer Causes Control (2010) 21:301–311
123supportive of an antiestrogenic effect of smoking on breast
tissue, is counter to the known increased risk of breast
cancer associated with smoking prior to FFTB. Thus, we
conclude that the antiestrogenic but not the carcinogenic
effects of smoking may be reﬂected by breast density.
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